Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

China CDC experts suggest survey on cold-chain suppliers to Wuhan in WHO’s 2nd-phase probe on virus origins
China CDC experts suggest survey on cold-chain suppliers to Wuhan in WHO’s 2nd-phase probe on virus origins
Amid the consensus among worldwide scientists that the second phase of the study on coronavirus origins should be carried out in multiple places, officials and experts from the Chinese Center for Dise...
Roche withdraws US approval for Tecentriq in mTNBC
Roche withdraws US approval for Tecentriq in mTNBC
Roche has voluntarily withdrawn its US accelerated approval for Tecentriq (atezolizumab) in combination with chemotherapy for the treatment of adults with unresectable locally advanced or meta...
Catalent to Extend Leadership in Rapidly Growing Nutraceuticals Market with Proposed $1 Billion Acquisition of Bettera, a Leading Gummies Manufacturer
Catalent to Extend Leadership in Rapidly Growing Nutraceuticals Market with Proposed $1 Billion Acquisition of Bettera, a Leading Gummies Manufacturer
SOMERSET, N.
RedHill Biopharma's Opaganib Demonstrates Strong Inhibition of COVID-19 Delta Variant
RedHill Biopharma's Opaganib Demonstrates Strong Inhibition of COVID-19 Delta Variant
TEL AVIV, Israel and RALEIGH, N.
Sesen Bio Pulls EU Application for Cancer Drug FDA Rejected
Sesen Bio Pulls EU Application for Cancer Drug FDA Rejected
Sesen Bio has withdrawn its EU marketing authorization application for Vysyneum (oportuzumab monatox-qqrs) ― called Vicineum in the U.
CellMax Life’s Cancer Blood Test Designated FDA Breakthrough Device
CellMax Life’s Cancer Blood Test Designated FDA Breakthrough Device
Molecular diagnostics company CellMax Life’s FirstSight pre-cancer and cancer detection blood test has received the FDA’s Breakthrough Device designation.
FDA approves MicroTransponder Vivistim Paired VNS System
FDA approves MicroTransponder Vivistim Paired VNS System
Vivistim is claimed to be the first-of-its-kind system to treat moderate to severe upper extremity motor deficits associated with chronic ischemic stroke using vagus nerve stimulationMicroTransponder ...
Sony's head of AI research wants to build robots that can win a Nobel Prize
Sony's head of AI research wants to build robots that can win a Nobel Prize
AI and Machine Learning systems have proven a boon to scientific research in a variety of academic fields in recent years.
EMA fast-tracks Marinus Pharma’s rare epilepsy treatment
EMA fast-tracks Marinus Pharma’s rare epilepsy treatment
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has approved Marinus Pharmaceuticals’ request for accelerated assessment of its lead p...
New machine learning method enhances computational prediction of RNA structures
New machine learning method enhances computational prediction of RNA structures
Researchers present ARES (Atomic Rotationally Equivariant Scorer) – a machine learning method that significantly improves the computational prediction of RNA structures over previous approac...
BioMarin climbs as dwarfism drug improves growth in children
BioMarin climbs as dwarfism drug improves growth in children
Aug 27.
NICE ‘no’ for Janssen’s Darzalex combo
NICE ‘no’ for Janssen’s Darzalex combo
The National Institute for Health and Care Excellence (NICE) has published draft guidance stating that it does not recommend Janssen’s Darzalex (daratumumab) plus bortezomib, thalido...
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand